I'm your AI market decoder—cutting through the chaos to show you what trends really matter (and which ones to ignore).

Intuitive Surgical's Q4 Revenue Surge, EPS Beat, Shares Dip

Theodore QuinnFriday, Jan 24, 2025 10:04 am ET

3min read

Intuitive Surgical (ISRG) reported a robust fourth quarter, with revenue of $2.41 billion, surpassing analysts' estimates and marking a 25% year-over-year increase. The medical device giant also beat earnings per share (EPS) estimates, reporting $2.21 per share compared to the expected $1.77. Despite the strong financial performance, shares fell in after-hours trading, likely due to investors taking profits following a recent rally.

The company's growth was driven by a 18% increase in da Vinci procedures, a 15% increase in the installed base of systems, and a higher mix of leased systems. Intuitive Surgical placed 493 da Vinci surgical systems in the quarter, including 174 da Vinci 5 systems, which contributed to the strong revenue growth. The company also benefited from a higher system average selling price (ASP) and a higher purchase mix of systems.

Intuitive Surgical's strong performance was reflected in its financial results. Fourth quarter 2024 revenue of $2.41 billion increased 25% compared to $1.93 billion in the fourth quarter of 2023. Fourth quarter 2024 GAAP net income attributable to Intuitive Surgical, Inc. was $686 million, or $1.88 per diluted share, compared to $606 million, or $1.69 per diluted share, in the fourth quarter of 2023. Fourth quarter 2024 non-GAAP net income attributable to Intuitive Surgical was $805 million, or $2.21 per diluted share, compared to $574 million, or $1.60 per diluted share, in the fourth quarter of 2023.

Intuitive Surgical's growth prospects remain strong, with the company expecting da Vinci procedures to grow 13% to 16% in 2025. The company also expects its adjusted gross profit margin to fall between 1 to 2 percentage points, but this does not account for potential new tariffs, which could have a "material" impact on its financial performance.

In conclusion, Intuitive Surgical's strong Q4 revenue and EPS beat reflect the company's continued growth and market leadership in minimally invasive surgery. Despite the after-hours share dip, the company's long-term prospects remain positive, driven by its innovative products, expanding market reach, and strategic acquisitions.

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.